Danielle Jenkins

Danielle Jenkins

Auto-generated profile, based on publicly available information

Danielle Jenkins

Pathology and Molecular Medicine, Queen’s University, Kingston, Canada. 3

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2024 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
PYPriyanka Yolmo
Priyanka Yolmo
SRSadaf Rahimi
Sadaf Rahimi
SCStephen Chenard
Stephen Chenard
GCGwenaëlle Conseil
Gwenaëlle Conseil
DJDanielle Jenkins
Danielle Jenkins
MKMadhuri Koti
Madhuri Koti
Poor response to Bacillus Calmette-Guérin (BCG) immunotherapy remains a major barrier in the management of patients with non–muscle invasive bladder cancer (NMIBC). Multiple factors are associated with poor outcomes, including biological aging and female sex. More recently, it has emerged that a B-cell–infiltrated pretreatment immune microenvironment of NMIBC tumors can influence the response to intravesically administered BCG. The mechanisms underlying the roles of B cells in NMIBC are poorly understood. Here, we show that B-cell–dominant tertiary lymphoid structures (TLSs), a hallmark feature of the chronic mucosal immune response, are abundant and located close to the epithelial compartment in pretreatment tumors from BCG non-responders. Digital spatial proteomic profiling of whole tumor sections from male and female patients with NMIBC who underwent treatment with intravesical BCG, revealed higher expression of immune exhaustion–associated proteins within the tumor-adjacent TLSs in both responders and non-responders. Chronic local inflammation, induced by the N-butyl-N-(4-hydroxybutyl) nitrosamine carcinogen, led to TLS formation with recruitment and differentiation of the immunosuppressive atypical B-cell (ABC) subset within the bladder microenvironment, predominantly in aging female mice compared to their male counterparts. Depletion of ABCs simultaneous to BCG treatment delayed cancer progression in female mice. Our findings provide evidence indicating a role for ABCs in BCG response and will inform future development of therapies targeting the B-cell–exhaustion axis.

1 October 2024
Verified
Other
Open access
PYPriyanka Yolmo
Priyanka Yolmo
SRSadaf Rahimi
Sadaf Rahimi
SCStephen Chenard
Stephen Chenard
GCGwenaëlle Conseil
Gwenaëlle Conseil
DJDanielle Jenkins
Danielle Jenkins
MKMadhuri Koti
Madhuri Koti
Contour plots showing myeloid and T cell populations.

17 June 2026
Verified
Other
Open access
PYPriyanka Yolmo
Priyanka Yolmo
SRSadaf Rahimi
Sadaf Rahimi
SCStephen Chenard
Stephen Chenard
GCGwenaëlle Conseil
Gwenaëlle Conseil
DJDanielle Jenkins
Danielle Jenkins
MKMadhuri Koti
Madhuri Koti
Poor response to Bacillus Calmette-Guérin (BCG) immunotherapy remains a major barrier in the management of patients with non–muscle invasive bladder cancer (NMIBC). Multiple factors are associated with poor outcomes, including biological aging and female sex. More recently, it has emerged that a B‐cell–infiltrated pretreatment immune microenvironment of NMIBC tumors can influence the response to intravesically administered BCG. The mechanisms underlying the roles of B cells in NMIBC are poorly understood. Here, we show that B‐cell–dominant tertiary lymphoid structures (TLSs), a hallmark feature of the chronic mucosal immune response, are abundant and located close to the epithelial compartment in pretreatment tumors from BCG non-responders. Digital spatial proteomic profiling of whole tumor sections from male and female patients with NMIBC who underwent treatment with intravesical BCG, revealed higher expression of immune exhaustion–associated proteins within the tumor-adjacent TLSs in both responders and non-responders. Chronic local inflammation, induced by the N-butyl-N-(4-hydroxybutyl) nitrosamine carcinogen, led to TLS formation with recruitment and differentiation of the immunosuppressive atypical B‐cell (ABC) subset within the bladder microenvironment, predominantly in aging female mice compared to their male counterparts. Depletion of ABCs simultaneous to BCG treatment delayed cancer progression in female mice. Our findings provide evidence indicating a role for ABCs in BCG response and will inform future development of therapies targeting the B‐cell–exhaustion axis.

17 June 2026
Verified
Other
Open access
PYPriyanka Yolmo
Priyanka Yolmo
SRSadaf Rahimi
Sadaf Rahimi
SCStephen Chenard
Stephen Chenard
GCGwenaëlle Conseil
Gwenaëlle Conseil
DJDanielle Jenkins
Danielle Jenkins
MKMadhuri Koti
Madhuri Koti
Splenic ABC expansion is enhanced by a combination of BBN exposure and BCG treatment.

17 June 2026
Verified
Other
Open access
PYPriyanka Yolmo
Priyanka Yolmo
SRSadaf Rahimi
Sadaf Rahimi
SCStephen Chenard
Stephen Chenard
GCGwenaëlle Conseil
Gwenaëlle Conseil
DJDanielle Jenkins
Danielle Jenkins
MKMadhuri Koti
Madhuri Koti
Effect of transient B‐cell depletion and BBN exposure on urothelium of BBN exposed female and male mice.

17 June 2026
Verified
Other
Open access
PYPriyanka Yolmo
Priyanka Yolmo
SRSadaf Rahimi
Sadaf Rahimi
SCStephen Chenard
Stephen Chenard
GCGwenaëlle Conseil
Gwenaëlle Conseil
DJDanielle Jenkins
Danielle Jenkins
MKMadhuri Koti
Madhuri Koti
BBN exposure and BCG treatment alters plasma immunoglobulin profiles in a sex differential manner.